by admin | Jun 20, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Isabella Ciccone, MPH – Nueurology Live – Recently, the FDA granted regenerative medicine advanced therapy (RMAT) designation to uniQure’s investigational Huntington disease (HD) gene therapy AMT-130 based on interim data from a phase 1/2 trial...
by admin | Jun 19, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Ryan Browne – CNBC – PARIS, France — French beauty and cosmetics giant L’Oreal is working on a form of synthetically produced skin that it says will one day be able to “feel” like we do. At the Viva Technology conference in Paris last...
by admin | Jun 18, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Letisia Marquez – City of Hope – Treating prostate cancer with immunotherapy is currently difficult to do. But preliminary results from a first in-human phase 1 trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from...
by admin | Jun 17, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Alejandra Manjarrez, PhD – Drug Discovery News – Researchers harvest stem cells from patients who have recently had a heart attack and use them to trigger regeneration of their cardiac muscle. For many people, surviving a heart attack is just the...
by admin | Jun 14, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by YUTA MAEDA – Nikkei – TOKYO — A Japanese startup is poised to become the first in the world to seek government approval for a therapy derived from human induced pluripotent stem (iPS) cells, Nikkei has learned, with a less invasive alternative for...
